We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Select Medical Distributes Concentra Shares to Shareholders
Read MoreHide Full Article
Hospital operator Select Medical Holdings Corporation (SEM - Free Report) recently completed the spin-off of Concentra Group Holdings Parent, Inc. (CON - Free Report) by distributing its 81.7% ownership stake in the company to its shareholders. Per the previously announced distribution plan, Select Medical distributed 104,093,503 shares of Concentra’s common stock.
This was done through a pro-rata stock distribution, where shareholders of SEM received 0.806971 shares of Concentra common stock for each share of SEM they held as of the record date, Nov. 18, 2024. Following the spin-off, SEM no longer owns any shares in Concentra, effectively separating the two companies.
Shareholders were also compensated in cash for any fractional shares of Concentra. This strategic move streamlines SEM’s operations and enables the company to focus on its core business areas, such as critical illness recovery hospitals, rehabilitation hospitals and outpatient rehabilitation clinics. It generated revenues of $583 million in the third quarter from critical illness recovery hospitals, $282.7 million from rehabilitation hospitals and $312 million from outpatient rehabilitation.
By separating from Concentra, which specializes in occupational health services, SEM can better allocate resources to its primary segments. For SEM’s shareholders, the spin-off offers an opportunity to hold shares in two different companies, potentially unlocking value in both.
The company completed the IPO of Concentra in July 2024 and it started trading on NYSE from July 25. Concentra has a massive network of 549 occupational health centers across 45 states and serves more than 50,000 patients per day on average.
Price Performance of SEM
Select Medical’s shares have gained 64.7% in the year-to-date period compared with the 6.7% growth of the industry it belongs to.
The Zacks Consensus Estimate for CareDx’s current-year earnings indicates a 162.5% year-over-year improvement. CDNA beat earnings estimates in each of the trailing four quarters, with an average surprise of 135.2%. The consensus mark for revenues implies 17.5% growth from the year-ago period.
The Zacks Consensus Estimate for Encompass Health’s 2024 earnings implies a 17.6% increase from the year-ago reported figure. EHC beat earnings estimates in each of the trailing four quarters, with an average surprise of 13.6%. The consensus mark for its current-year revenues is pegged at $5.34 billion, which indicates an 11.2% year-over-year increase.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Select Medical Distributes Concentra Shares to Shareholders
Hospital operator Select Medical Holdings Corporation (SEM - Free Report) recently completed the spin-off of Concentra Group Holdings Parent, Inc. (CON - Free Report) by distributing its 81.7% ownership stake in the company to its shareholders. Per the previously announced distribution plan, Select Medical distributed 104,093,503 shares of Concentra’s common stock.
This was done through a pro-rata stock distribution, where shareholders of SEM received 0.806971 shares of Concentra common stock for each share of SEM they held as of the record date, Nov. 18, 2024. Following the spin-off, SEM no longer owns any shares in Concentra, effectively separating the two companies.
Shareholders were also compensated in cash for any fractional shares of Concentra. This strategic move streamlines SEM’s operations and enables the company to focus on its core business areas, such as critical illness recovery hospitals, rehabilitation hospitals and outpatient rehabilitation clinics. It generated revenues of $583 million in the third quarter from critical illness recovery hospitals, $282.7 million from rehabilitation hospitals and $312 million from outpatient rehabilitation.
By separating from Concentra, which specializes in occupational health services, SEM can better allocate resources to its primary segments. For SEM’s shareholders, the spin-off offers an opportunity to hold shares in two different companies, potentially unlocking value in both.
The company completed the IPO of Concentra in July 2024 and it started trading on NYSE from July 25. Concentra has a massive network of 549 occupational health centers across 45 states and serves more than 50,000 patients per day on average.
Price Performance of SEM
Select Medical’s shares have gained 64.7% in the year-to-date period compared with the 6.7% growth of the industry it belongs to.
Image Source: Zacks Investment Research
SEM’s Zacks Rank & Other Key Picks
Select Medical currently has a Zacks Rank #2 (Buy). Some other top-ranked and promising stocks in the broader Medical sector are CareDx, Inc (CDNA - Free Report) and Encompass Health Corporation (EHC - Free Report) , each carrying a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for CareDx’s current-year earnings indicates a 162.5% year-over-year improvement. CDNA beat earnings estimates in each of the trailing four quarters, with an average surprise of 135.2%. The consensus mark for revenues implies 17.5% growth from the year-ago period.
The Zacks Consensus Estimate for Encompass Health’s 2024 earnings implies a 17.6% increase from the year-ago reported figure. EHC beat earnings estimates in each of the trailing four quarters, with an average surprise of 13.6%. The consensus mark for its current-year revenues is pegged at $5.34 billion, which indicates an 11.2% year-over-year increase.